Literature DB >> 11774197

Biological agents: weapons of warfare and bioterrorism.

L A Broussard1.   

Abstract

The use of microorganisms as agents of biological warfare is considered inevitable for several reasons, including ease of production and dispersion, delayed onset, ability to cause high rates of morbidity and mortality, and difficulty in diagnosis. Biological agents that have been identified as posing the greatest threat are variola major (smallpox), Bacillus anthracis (anthrax), Yersinia pestis (plague), Clostridium botulinum toxin (botulism), Francisella tularensis (tularaemia), filoviruses (Ebola hemorrrhagic fever and Marburg hemorrhagic fever), and arenaviruses Lassa (Lassa fever) and Junin (Argentine hemorrhagic fever). The pathogenesis, clinical manifestations, diagnosis, and treatment of these agents are discussed. Rapid identification and diagnosis using molecular diagnostic techniques such as PCR is an essential element in the establishment of coordinated laboratory response systems and is the focus of current research and development. Molecular techniques for detection and identification of these organisms are reviewed.

Entities:  

Mesh:

Year:  2001        PMID: 11774197     DOI: 10.1054/modi.2001.29155

Source DB:  PubMed          Journal:  Mol Diagn        ISSN: 1084-8592


  20 in total

1.  Myristoylation of the RING finger Z protein is essential for arenavirus budding.

Authors:  Mar Perez; Dori L Greenwald; Juan Carlos de la Torre
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

2.  Characterization of botulinum neurotoxin type A neutralizing monoclonal antibodies and influence of their half-lives on therapeutic activity.

Authors:  Christelle Mazuet; Julie Dano; Michel R Popoff; Christophe Créminon; Hervé Volland
Journal:  PLoS One       Date:  2010-08-26       Impact factor: 3.240

3.  Genetic and biochemical evidence for an oligomeric structure of the functional L polymerase of the prototypic arenavirus lymphocytic choriomeningitis virus.

Authors:  Ana B Sánchez; Juan C de la Torre
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

Review 4.  Persistence of category A select agents in the environment.

Authors:  Ryan Sinclair; Stephanie A Boone; David Greenberg; Paul Keim; Charles P Gerba
Journal:  Appl Environ Microbiol       Date:  2007-12-07       Impact factor: 4.792

Review 5.  Interaction between Yersinia pestis and the host immune system.

Authors:  Bei Li; Ruifu Yang
Journal:  Infect Immun       Date:  2008-02-04       Impact factor: 3.441

6.  Detection of botulinum neurotoxin serotype A, B, and F proteolytic activity in complex matrices with picomolar to femtomolar sensitivity.

Authors:  F Mark Dunning; Daniel R Ruge; Timothy M Piazza; Larry H Stanker; Füsûn N Zeytin; Ward C Tucker
Journal:  Appl Environ Microbiol       Date:  2012-08-24       Impact factor: 4.792

7.  Safety and pharmacokinetics of XOMA 3AB, a novel mixture of three monoclonal antibodies against botulinum toxin A.

Authors:  S U Nayak; J M Griffiss; R McKenzie; E J Fuchs; R A Jurao; A T An; A Ahene; M Tomic; C W Hendrix; J M Zenilman
Journal:  Antimicrob Agents Chemother       Date:  2014-06-09       Impact factor: 5.191

8.  RNA interference-mediated virus clearance from cells both acutely and chronically infected with the prototypic arenavirus lymphocytic choriomeningitis virus.

Authors:  Ana B Sánchez; Mar Perez; Tatjana Cornu; Juan Carlos de la Torre
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

9.  Simultaneous Detection of CDC Category "A" DNA and RNA Bioterrorism Agents by Use of Multiplex PCR & RT-PCR Enzyme Hybridization Assays.

Authors:  Jie He; Andrea J Kraft; Jiang Fan; Meredith Van Dyke; Lihua Wang; Michael E Bose; Marilyn Khanna; Jacob A Metallo; Kelly J Henrickson
Journal:  Viruses       Date:  2009       Impact factor: 5.048

10.  MLVA distribution characteristics of Yersinia pestis in China and the correlation analysis.

Authors:  Xiaoai Zhang; Rong Hai; Jianchun Wei; Zhigang Cui; Enmin Zhang; Zhizhong Song; Dongzheng Yu
Journal:  BMC Microbiol       Date:  2009-09-23       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.